Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Just One Canadian Ginseng Extract is a dietary supplement developed through a collaboration between OPC Pharmaceutical Joint Stock Company (OPC Pharma) and Canadian Vita Corporation. It is formulated as a liquid extract of Canadian ginseng (Panax quinquefolius) in a 2:1 concentration ratio, where each gram of concentrated extract is derived from two grams of pure Canadian ginseng. The product is available in two formulations: a honey-sweetened version (JUST ONE Honey) and a sugar-free version sweetened with natural red apple and stevia. It is designed to support overall health, boost immunity, reduce fatigue, and increase resistance. It is packaged in convenient 15 ml single-use sachets and 50 ml bottles for oral administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Just One Canadian Ginseng Extract.